The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1438
March 17, 2014
View Complete Issue         Table of Contents 2019 
Intranasal Naloxone for Treatment of Opioid Overdose
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Intranasal Naloxone for Treatment of Opioid Overdose
March 17, 2014 (Issue: 1438)
The recent increase in deaths from heroin overdose in the US has led to renewed interest in the opioid antagonist naloxone, particularly in making it available as an intranasal spray to paramedics and possibly to relatives and close friends of...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Intranasal Naloxone for Treatment of Opioid Overdose
Article code: 1438b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.